MacCarrone M et al. |
Human platelets bind and degrade 2-arachidonoylglycerol, which activates these cells through a cannabinoid receptor. |
2001 |
Eur. J. Biochem. |
pmid:11168423
|
Bisogno T et al. |
The uptake by cells of 2-arachidonoylglycerol, an endogenous agonist of cannabinoid receptors. |
2001 |
Eur. J. Biochem. |
pmid:11277920
|
Di Marzo V et al. |
Biosynthesis and inactivation of the endocannabinoid 2-arachidonoylglycerol in circulating and tumoral macrophages. |
1999 |
Eur. J. Biochem. |
pmid:10447696
|
Matias I et al. |
Presence and regulation of the endocannabinoid system in human dendritic cells. |
2002 |
Eur. J. Biochem. |
pmid:12153574
|
Di Marzo V et al. |
Role of insulin as a negative regulator of plasma endocannabinoid levels in obese and nonobese subjects. |
2009 |
Eur. J. Endocrinol. |
pmid:19745037
|
Sido JM et al. |
Production of endocannabinoids by activated TÂ cells and BÂ cells modulates inflammation associated with delayed-type hypersensitivity. |
2016 |
Eur. J. Immunol. |
pmid:27064137
|
Ryan D et al. |
Interactions of cannabidiol with endocannabinoid signalling in hippocampal tissue. |
2007 |
Eur. J. Neurosci. |
pmid:17419758
|
Béquet F et al. |
CB1 receptor-mediated control of the release of endocannabinoids (as assessed by microdialysis coupled with LC/MS) in the rat hypothalamus. |
2007 |
Eur. J. Neurosci. |
pmid:18052990
|
Hájos N et al. |
Endocannabinoid transport tightly controls 2-arachidonoyl glycerol actions in the hippocampus: effects of low temperature and the transport inhibitor AM404. |
2004 |
Eur. J. Neurosci. |
pmid:15182306
|
Kortleven C et al. |
The endocannabinoid 2-arachidonoylglycerol inhibits long-term potentiation of glutamatergic synapses onto ventral tegmental area dopamine neurons in mice. |
2011 |
Eur. J. Neurosci. |
pmid:21410793
|
Nyilas R et al. |
Molecular architecture of endocannabinoid signaling at nociceptive synapses mediating analgesia. |
2009 |
Eur. J. Neurosci. |
pmid:19453631
|
Rea K et al. |
Microinjection of 2-arachidonoyl glycerol into the rat ventral hippocampus differentially modulates contextually induced fear, depending on a persistent pain state. |
2014 |
Eur. J. Neurosci. |
pmid:24494683
|
Petrenko AB et al. |
Genetic inactivation and prolonged pharmacologic inhibition of monoacylglycerol lipase have opposite effects on anesthetic sensitivity to propofol. |
2015 |
Eur. J. Pharmacol. |
pmid:26318148
|
Fride E et al. |
Milk intake and survival in newborn cannabinoid CB1 receptor knockout mice: evidence for a "CB3" receptor. |
2003 |
Eur. J. Pharmacol. |
pmid:12568912
|
Shimizu T and Yokotani K |
Bidirectional roles of the brain 2-arachidonoyl-sn-glycerol in the centrally administered vasopressin-induced adrenomedullary outflow in rats. |
2008 |
Eur. J. Pharmacol. |
pmid:18234185
|
Mechoulam R et al. |
Endocannabinoids. |
1998 |
Eur. J. Pharmacol. |
pmid:9831287
|
Shimizu T et al. |
Endogenously generated 2-arachidonoylglycerol plays an inhibitory role in bombesin-induced activation of central adrenomedullary outflow in rats. |
2011 |
Eur. J. Pharmacol. |
pmid:21371452
|
Stella N and Piomelli D |
Receptor-dependent formation of endogenous cannabinoids in cortical neurons. |
2001 |
Eur. J. Pharmacol. |
pmid:11513837
|
Ben-Shabat S et al. |
An entourage effect: inactive endogenous fatty acid glycerol esters enhance 2-arachidonoyl-glycerol cannabinoid activity. |
1998 |
Eur. J. Pharmacol. |
pmid:9721036
|
Oka S et al. |
Suppression by WIN55212-2, a cannabinoid receptor agonist, of inflammatory reactions in mouse ear: Interference with the actions of an endogenous ligand, 2-arachidonoylglycerol. |
2006 |
Eur. J. Pharmacol. |
pmid:16647054
|